Medtronic (MDT) DIvidends Date & History

Key Takeaways

• Medtronic pays a quarterly dividend of $0.72 per share, delivering an annualized yield of approximately 3.16%.
• The company has increased its dividend for 48 consecutive years, qualifying as a Dividend Aristocrat.
• Payout ratio stands near 76%, supported by strong free cash flow generation in the medical technology sector.
• Next ex-dividend date is September 25, 2026, with payment scheduled for October 16, 2026.
• Yield exceeds many healthcare peers, offering competitive income potential for dividend investors.
• Long-term dividend growth remains modest but consistent, aligning with stable demand for medical devices.

Dividend Overview

Medtronic plc (MDT) maintains a quarterly dividend policy focused on returning capital to shareholders while funding innovation in medical devices. The current annual dividend totals $2.88 per share, producing a yield of about 3.16% based on recent share prices. Payments occur four times per year, with the most recent quarterly amount at $0.72. The firm qualifies as a modest-yield dividend growth stock rather than a high-yield play, appealing to investors seeking steady income alongside moderate capital appreciation in the healthcare sector.

Dividend History and Growth

Medtronic has paid dividends since 1993 and raised the payout annually for 48 straight years. Annualized dividends have grown from $2.78 in 2024 to $2.88 recently, reflecting consistent but measured increases averaging around 1.4% year-over-year. This long streak underscores a disciplined capital allocation strategy that prioritizes dividend sustainability amid evolving healthcare needs and regulatory environments.

Dividend Sustainability and Payout Ratio

The payout ratio hovers near 76%, indicating dividends consume a substantial portion of earnings yet remain covered by robust free cash flow typical of established medical device manufacturers. Low debt levels relative to cash generation and steady demand for products like pacemakers and surgical systems support ongoing payments. No recent cuts have occurred, and financial metrics point to continued viability barring major economic disruptions.

Dividend Compared to Industry Peers

Medtronic’s yield of roughly 3.16% surpasses several sector counterparts, including Abbott Laboratories (ABT) at 2.21%, Johnson & Johnson (JNJ) at 1.97%, and Stryker (SYK) at 1.05%. While peers often feature lower payouts, MDT’s higher yield combined with its extended growth record positions it favorably among medical technology dividend stocks for income-oriented portfolios.

AI Screener

AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

Medtronic (MDT) suits conservative dividend growth investors and long-term income seekers who value a proven track record of annual increases and sector stability. Its yield provides meaningful income without the volatility of higher-yielding alternatives, though the moderate growth rate may appeal less to those prioritizing rapid dividend expansion. The company’s established position in essential healthcare technologies supports resilience across economic cycles, making it a balanced holding for portfolios emphasizing reliability over aggressive returns. Investors should weigh personal risk tolerance and portfolio diversification needs.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations